• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Why Relationships are Key When Caring For Patients With MPNs

by MM360 Staff | May 13, 2025 | Uncategorized

Source: CureToday articles Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence. Read More

Understanding the Unique Task of Treating Older Patients With Breast Cancer

by MM360 Staff | May 13, 2025 | Uncategorized

Source: CureToday articles Dr. Hyman B. Muss discusses the unique challenges that older patients with breast cancer face during and after treatment for their disease. Read More

I Found Strength After Surviving Multiple Myeloma and Through Recovery

by MM360 Staff | May 13, 2025 | Uncategorized

Source: CureToday articles I share how I survived multiple myeloma, painful spine fractures and years of recovery to reclaim my independence and vitality. Read More

Custom-Made Vaccine Combo Proves Effective in Bladder Cancer

by MM360 Staff | May 13, 2025 | Uncategorized

Source: CureToday articles Treatment with a custom-made vaccine combination was found to be safe and feasible for patients with bladder cancer, eliciting a strong immune response. Read More

Perjeta Regimen Improves Survival in HER2+ Early-Stage Breast Cancer

by MM360 Staff | May 13, 2025 | Uncategorized

Source: CureToday articles Treatment with Perjeta, Herceptin and chemotherapy post-surgery led to a significant overall survival benefit in HER2-positive early-stage breast cancer. Read More

Cracked, Not Broken: Life After Breast Cancer

by MM360 Staff | May 13, 2025 | Uncategorized

Source: CureToday articles Breast cancer cracked me open but didn’t break me — it gave me voice, purpose and courage to dream boldly, live fully and speak up for those who can’t. Read More
« Older Entries
Next Entries »

Recent Content

  • In vivo CAR-T exhibits activity in advanced multiple myeloma
  • FDA backs faster development of new therapy for hard-to-treat AML
  • The efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials
  • Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy
  • Correction: Chen et al. The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis. Diagnostics 2024, 14, 1030
  • Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials
  • Combo treatment may offer new hope to astrocytoma patients: Trial
  • Reduced-versus Standard-dose Melphalan as Single-agent Conditioning Regimen in Auto HSCT for Multiple Myeloma: A Systematic Review and Meta-Analysis
  • Dosing begins in trial testing Enhertu for ovarian cancer
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT